Search Results
Search for other papers by Sarantis Livadas in
Google Scholar
PubMed
Search for other papers by Christina Bothou in
Google Scholar
PubMed
Search for other papers by Justyna Kuliczkowska-Płaksej in
Google Scholar
PubMed
Search for other papers by Ralitsa Robeva in
Google Scholar
PubMed
Search for other papers by Andromahi Vryonidou in
Google Scholar
PubMed
Search for other papers by Jelica Bjekic Macut in
Google Scholar
PubMed
Search for other papers by Ioannis Androulakis in
Google Scholar
PubMed
Search for other papers by Milica Opalic in
Google Scholar
PubMed
Search for other papers by Zadalla Mouslech in
Google Scholar
PubMed
Search for other papers by Andrej Milewicz in
Google Scholar
PubMed
Search for other papers by Alessandra Gambineri in
Google Scholar
PubMed
Search for other papers by Dimitrios Panidis in
Google Scholar
PubMed
Search for other papers by Djuro Macut in
Google Scholar
PubMed
optimal method to detect potential dysglycemia ( 12 ). Moreover, the most accurate means for testing hyperglycemia including fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), or hemoglobin A1c (HbA1c) has to be clarified ( 13 ). Several
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Liliana Fonseca in
Google Scholar
PubMed
Search for other papers by Maria Teresa Pereira in
Google Scholar
PubMed
Search for other papers by Joana Vilaverde in
Google Scholar
PubMed
Search for other papers by Clara Pinto in
Google Scholar
PubMed
Search for other papers by Fernando Pichel in
Google Scholar
PubMed
Search for other papers by Maria do Céu Almeida in
Google Scholar
PubMed
Search for other papers by Jorge Dores in
Google Scholar
PubMed
through the measurement of fasting plasma glucose (PG) and, if this result was normal, between the 24th and 28th weeks of gestation with the 75-g 2-h oral glucose tolerance test (OGTT). In this study, the GDM diagnosis was established in the presence of
Search for other papers by Giovanni Fanni in
Google Scholar
PubMed
Search for other papers by Petros Katsogiannos in
Google Scholar
PubMed
Search for other papers by Bipasha Nandi Jui in
Google Scholar
PubMed
Search for other papers by Magnus Sundbom in
Google Scholar
PubMed
Search for other papers by Susanne Hetty in
Google Scholar
PubMed
Search for other papers by Maria J Pereira in
Google Scholar
PubMed
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
affects endocrine responses to this aminoacidic stimulus ( 18 ). The oral glucose tolerance test (OGTT) is a standardized technique to assess the metabolic and overall hormonal response to an oral glucose load and is a validated diagnostic tool for
Search for other papers by Michelle J Galvan in
Google Scholar
PubMed
Search for other papers by Michael J Sanchez in
Google Scholar
PubMed
Australian Institute for Musculoskeletal Science (AIMSS), Victoria University, Melbourne, Victoria, Australia
Search for other papers by Andrew J McAinch in
Google Scholar
PubMed
Search for other papers by Jeffrey D Covington in
Google Scholar
PubMed
Search for other papers by Jason B Boyle in
Google Scholar
PubMed
Search for other papers by Sudip Bajpeyi in
Google Scholar
PubMed
flexions and extensions of the dominant limb (at 60° per second). Dietary control Participants were provided with food for 2 days prior to OGTT to control the dietary effects on insulin sensitivity and blood profile. Meals were designed to comply
Surgery Research Unit, Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
Search for other papers by Olli Helminen in
Google Scholar
PubMed
Search for other papers by Tytti Pokka in
Google Scholar
PubMed
Search for other papers by Susanna Aspholm in
Google Scholar
PubMed
Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland
Search for other papers by Jorma Ilonen in
Google Scholar
PubMed
Search for other papers by Olli G Simell in
Google Scholar
PubMed
Pediatric Research Center, New Children’s Hospital, Helsinki University Hospital, Helsinki, Finland
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Search for other papers by Mikael Knip in
Google Scholar
PubMed
Search for other papers by Riitta Veijola in
Google Scholar
PubMed
glucose tolerance test (OGTT) ( 9 ), random plasma glucose ( 9 ), C-peptide ( 10 ) and intravenous glucose tolerance test ( 11 ) can predict the timing of the diagnosis. For secondary prevention studies, the ability to predict the time and risk of the
Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed
Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed
Search for other papers by Sally Abbott in
Google Scholar
PubMed
Search for other papers by Tin Chan in
Google Scholar
PubMed
Search for other papers by Sanesh Pillai in
Google Scholar
PubMed
Search for other papers by Kate Maslin in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK
Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed
Search for other papers by Barbara McGowan in
Google Scholar
PubMed
Search for other papers by Rob Andrews in
Google Scholar
PubMed
Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed
Search for other papers by Katherine McCullough in
Google Scholar
PubMed
Search for other papers by Lorraine Albon in
Google Scholar
PubMed
Search for other papers by Rachel Batterham in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Shareen Forbes in
Google Scholar
PubMed
Search for other papers by Gavin Bewick in
Google Scholar
PubMed
Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed
phenomenon is possibly related to higher pre-operative β-cell function, insulin secretion and sensitivity ( 24 ). Indeed, the presence of pre-operative hypoglycaemia during an oral glucose tolerance test (OGTT) is associated with PBH ( 25 ). Other possible
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed
Search for other papers by Luigi Maione in
Google Scholar
PubMed
Search for other papers by Sylvie Salenave in
Google Scholar
PubMed
Search for other papers by Jacques Young in
Google Scholar
PubMed
Search for other papers by Peter Kamenický in
Google Scholar
PubMed
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
patients, data on blood glucose, insulin and GH at 0, 30, 60, 90 and 120 min during oral glucose tolerance tests (OGTTs) before and after initiation of pasireotide were available. Based on dynamic changes in glucose and insulin concentrations during the
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine R Carlander in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Julie L Forman in
Google Scholar
PubMed
Search for other papers by Joachim Størling in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Holst in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
sampling. CGM, continuous glucose monitoring; MRS, magnetic resonance spectroscopy; OGTT, oral glucose tolerance test. Eligibility criteria Key inclusion criteria included male sex, age above 18 years, BMI above 24.9 kg/m 2 and otherwise
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Danish Diabetes Academy, Odense University Hospital, Odense, Denmark
Search for other papers by Katrine M Lauritsen in
Google Scholar
PubMed
Search for other papers by Jens Hohwü Voigt in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Steen Bønløkke Pedersen in
Google Scholar
PubMed
Search for other papers by Troels K Hansen in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Niels Møller in
Google Scholar
PubMed
Department of Biomedicine, Aarhus University, Aarhus, Denmark
Search for other papers by Niels Jessen in
Google Scholar
PubMed
Search for other papers by Lars C Gormsen in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Danish Diabetes Academy, Odense University Hospital, Odense, Denmark
Search for other papers by Esben Søndergaard in
Google Scholar
PubMed
indirect calorimetry (Jaeger Oxycon Pro, Intra medic and Deltatrac II, Datex; Gentofte, Denmark) to measure resting energy expenditure (EE) and respiratory quotient (RQ). Finally, a standard oral glucose tolerance test (OGTT) was performed with consumption
Search for other papers by Chenyu Jiang in
Google Scholar
PubMed
Search for other papers by Mi Zhou in
Google Scholar
PubMed
Search for other papers by Huai Bai in
Google Scholar
PubMed
Search for other papers by Meng Chen in
Google Scholar
PubMed
Search for other papers by Chunyi Yang in
Google Scholar
PubMed
Search for other papers by Kaifeng Hu in
Google Scholar
PubMed
Search for other papers by Yujie Wu in
Google Scholar
PubMed
Search for other papers by Qingqing Liu in
Google Scholar
PubMed
Search for other papers by Yangyu Zhao in
Google Scholar
PubMed
Search for other papers by Xinghui Liu in
Google Scholar
PubMed
Search for other papers by Ping Fan in
Google Scholar
PubMed
pregnant woman was subjected to a 75 g oral glucose tolerance test (OGTT) between 24 and 28 weeks of gestation. GDM was diagnosed according to the guidelines of the International Association of Diabetes Pregnancy Study Groups by a woman having one or more